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1   Abstract 
Introduction: Antiseptics are used for the prophylaxis of infections of acute wounds and 
for the treatment of critically colonized chronic wounds as well as localized infections of 
acute and chronic wounds. If an antiseptic with too much tissue toxicity and/or too little 
efficacy is used, the wound healing can be delayed. 
Objective: The aim was to compare the irritation potency of frequently used wound 
antiseptics by using the hen's egg test on the chorioallantoic membrane (HET-CAM). 
Additionally, the influence of antiphlogistic active additives which might increase the 
tolerability was examined. To allow a more extensive comparison, antiseptics classified 
as obsolete such as hydrogen peroxide, creams on PVP- iodine base, silver sulfadiazine, 
chlorhexidine and nitrofural as well as the non-antiseptic wound treatment agents 
dexpanthenol and hemoglobin spray were also examined. 
Method: The HET-CAM was used as a semi-in-vivo method to test the tolerability of 
wound antiseptics to tissues by observing the reactions that occur in the blood vessels 
of the highly vascularized CAM such as hemorrhage, lysis and coagulation. The irritation 
score (IS) was calculated and differentiated in 4 ranges according to Spielmann (1991). 
Results: The vascular injuries of the CAM were considered as an indirect indicator of 
the tolerability. It is accepted that agents with no or low irritation potential on the CAM 
are to be preferred in the clinical practice if they are clinically effective.  
Severe CAM reaction was observed after short-term application of octenidine based 
wound gel (active ingredient octenidine 0.05%) (IS: 10.3) and chlorhexidine digluconate 
0.5% solution (IS: 9.5). Moderate reaction was observed for the combination of 
octenidine 0.05% in aqueous solution with panthenol 1.34% and allantoin 0.2% (IS: 8.7), 
hydrogen peroxide 1.5% in aqueous solution (IS: 6.1) and hydrogen peroxide 0.5% 
solution (IS: 5.5). Slight reaction was observed for hydrogen peroxide 1.5% solution in 
combination with sodium thiocyanate 0.698% (IS: 2.6), sodium thiocyanate 0.698% 
solution (IS: 2.1) and Dermacyn® (active ingredient NaOCl/HOCl each 0.004) (IS: 1.2). 
Polihexanide 0.04% in Ringer solution (IS: 0.9), Polihexanide 0.05% in Lipofundin, 
Granulox® (active agent hemoglobin 10%) (IS: 0) and dexpanthenol 5% solution (IS: 0) 
showed no reaction. In the long-term observation (24 hours after application), 
Dermacyn® showed the best results (59% of irritation remained alive after 24 hours). The 
addition of dexpanthenol and allantoin reduced the irritability only slightly, whereas the 
decrease of IS of hydrogen peroxide by addition of sodium thiocyanate was almost 
significant (p 0.0596). 
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Conclusion: It is suggested that agents with no or low irritation potential on the CAM 
are to be preferred in the clinical practice if they are clinically effective. It is suggested 
that further in vivo and in vitro studies are to be undertaken with these agents.  
Solely regarding local tolerability, polihexanide and hypochlorite are the antiseptic agents 
of choice of the tested preparations. The wound oxygenizer hemoglobin spray is 
tolerated without irritation as well as the negative control 0.9% NaCl solution. Because 
of their other disadvantages in conjunction with their irritability, the outdated cream 
formulations on basis of silver sulfadiazine, PVP- iodine, chlorhexidine and nitrofural 
cannot be recommended for wound antisepsis. 
Keywords: Wound antiseptics, HET-CAM, irritation score, octenidine, chlorhexidine, 
















2   Introduction   
2.1 Aim 
Antiseptic solutions, ointments and dressings are used for both prophylaxis of infections 
of acute wounds and treatment of critically colonized chronic wounds as well as localized 
infections of acute and chronic wounds (Kramer 2016, Kramer et al. 2013, 2016, 2017). 
Although antiseptics are used widely to make the healing time shorter, unfortunately, 
they may prolong the healing duration because of their cytotoxicity towards the wound 
tissue (Bolton et al. 1985, Kramer et al. 1998). 
 
There is a question that I have personally encountered numerous times during my day 
to day work: Which antiseptic is the most tolerable one with the least irritation or side 
effects in short and long-term application? The aim of this study is to help finding answer 
to this question.  
 
The intention is to create a comparison between the irritation potencies of selected 
wound antiseptics including the influence of antiphlogistic active additives, which may 
improve the tolerability, to give an option for further research. 
 
A sensitive screening model to analyze the tolerability of wound antiseptics in vivo is the 
Hens’ Egg test on the chorioallantoic membrane (HET-CAM) of chicken embryos. The 
HET-CAM was originally developed by Spielmann et al. (1991) to replace the Draize 
irritation test (Draize et al. 1944). In addition, the HET-CAM was used as a model for 
investigation of inflammation and angiogenesis (Dannhardt et al. 1996, Krenn and Paper 
2009, Ribatti et al. 1996, Zwadlo-Klarwasser et al. 2001) as well as to test the 
mutagenicity (Kluge et al. 2016). 
 
In the present work, the HET-CAM is used to test the tolerability of selected antiseptic 
active agents, commercially available wound antiseptics and possibly suitable additives 
for antiseptic formulations. 
 
The planned study differs from other similar projects in the following points: 
• The reliability of the sample means is higher, because the experiment was done on 
9 eggs for every substance, while other published data had used only 3-6 eggs. 
• The tolerability of the antiseptic to the tissue was observed 24 hours after application, 
which will help to recommend the less cytotoxic antiseptics for long exposure time. 
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• Although some of the antiseptics and formulations were tested before, the others are 
tested for the first time in this study. 
• Some of the tested formulations are suggested mixtures of agents and additives, 
which aim to give an option for the development of new combinations with better 
tolerability. 
 
2.2 The HET-CAM as a semi-in-vivo method to test the tolerability of wound 
antiseptics 
The Draize irritation test on the eyes of rabbits, a clearly in vivo test method, can be 
considered as the first published test to evaluate the tolerability of substances to living 
tissues. In his publication "Methods for the study of irritation and toxicity of substances 
applied topically to the skin and mucous membranes", Draize et al. (1944) describes how 
to use the animals such as rabbits to measure the irritation potency of substances on the 
skin and mucous membranes.  
 
The Draize irritation test was heavily criticized due to ethical reasons perspective 
because of the injuries of the tested animals. That is why several various tests have been 
developed to replace the rabbits in detecting the irritation potential of chemicals (Kishore 
et al. 2008). 
 
One of the alternative tests is the HET-CAM (hen’s egg test on the chorioallantoic 
membrane) which considered as an acceptable replacement scientifically and ethically. 
The HET-CAM avoids the ethical obstacle and allows enlarging the sample size.  
 
The CAM is produced as an extraembryonic mesodermal double layer on the 4th-6th 
embryo development day from the fusion of chorion and allantois (Fuchs and 
Lindenbaum 1988, Bellairs and Osmond 1998). The ectodermal chorion surrounds the 
embryo and the yolk (Rizzo and DeFouw 1993). In the double membrane, a dense 
vascular network develops, which is connected to the embryo via arteries and veins 
(Rizzo et al. 1995). On the 10th day of incubation, the capillary network overlays the area 
adjacent to the air bubble, which allows optical evaluation of the stimulus effect (DeFouw 
et al. 1989a, Fuchs and Lindenbaum 1988, Rizzo et al. 1995). During embryogenesis, 
the CAM can be found at the blunt pole of the egg near the air space. No nerve tissue 
develops in the chicken egg until the 11th day, so no pain perception occurs at the time 
of the experiment (Liebsch and Spielmann 2002); thus, testing the chicken egg is not be 




The vascular system of the CAM reacts to harmful substances immediately; it reacts 
highly sensitively and can be evaluated visually. The CAM reacts to stimuli similar to the 
mammalian eye, therefore the HET-CAM is suitable for the investigation of irritation and 
inflammation reactions and is used as a predictive model for eye tolerance (Steiling et 
al. 1999), as model for tolerability to wounds (Ribatti et al. 1999, Ribatti et al. 1996a) and 
as a precursor for the assessment of wound healing (Kramer et al. 2013). Since no 
established animal model exists for chronic wounds, the HET-CAM at least allows for an 
orientating assessment of tissue tolerability. It can be assumed that antiseptic agents 
tolerated by the HET-CAM are compatible with the eye and wounds. 
 
The first study to compare the irritation potential of antibiotic eye drops and the wound 
antiseptic polihexanide was done by Kramer and Behrens-Baumann (1997). Whereas 
polihexanide displayed no reaction on the CAM, the antibiotic eye drops (i.e. Posifenicol® 
and Dispaphenicol®) induced low to strong hyperemia and even sporadic hemorrhage. 
On this basis, it was possible to introduce the wound antiseptic polihexanide for 
preoperative eye antiseptic (Hansmann et al. 2004, 2005) and the surgical aphorism  "do 
not apply anything into the wound that you cannot apply on eye" was deduced (Leaper 
et al. 2010, Assadian u. Kramer 2012, Kramer et al. 2013). From this point of view, the 
HET-CAM was used as a predictive test for the suitability of a treatment for wounds. 
Thus, the HET-CAM formed the decisive prerequisite for the introduction of cold 
atmospheric pressure plasma (CAPP) for wound treatment (Kramer et al 2013). Because 
the plasma is antiseptically effective, including activity against biofilms, and stimulates 
mild inflammation, chronic wounds could be successfully treated with the CAP in various 
pet species without negative influence on wounds (Bender et al. 2010, 2011, 2012, 
Bender and Kramer 2016). Thus, the HET-CAM allowed a prediction in order to apply 
plasma to wounds. 
 
Considering the corresponding results of studies on the tolerability of antiseptics in cell 
culture (Müller and Kramer 2008), peritoneal explants (Kramer et al. 1998), HET-CAM 
(Kramer and Behrens-Baumann 1997, Reimer et al. 2000, Kramer et al. 2004, Roth et 
al. 2017), the HET-CAM was selected as a screening model for the tolerability of wound 
antiseptics to tissues in the present study. An additional aspect was that the HET-CAM, 
due to its high sensitivity, has a safety margin for the application of antiseptics on wounds 





2.3 Overview of common wound antiseptics as a base for the selection of relevant 
test substances 
In clinical practice, we choose the antiseptic which gives us the best results with the 
fewer side effects, so we give attention to the antiseptic's spectrum of activity, risk of 
development of resistance, cytotoxicity, absorption and systemic risks.  
 
Summarizing, polihexanide, octenidine and the combination of sodium hypochlorite and 
hypochloric acid or sodium hypochlorite by itself are at present the antiseptics of choice 
for both acute and chronic wounds (Kramer 2016, Kramer et al. 2017). The only 
exceptions are bite and stab wounds; these wounds are to be treated with a combination 
of iodophors and alcohols because they have better tissue penetration (Kramer et al. 
2012, 2017, Willy et al. 2017). Table 1 describes the most common wound antiseptics 














Table 1: Brief characterization of antiseptic agents (modified after Kramer et al. 2012, 2017) 
Active 
substance 













































































































First choice for 











Broad spectrum, loss of 
effectiveness in the presence 








antiseptic for stab 
and bite wounds 
Medihoney® Broad spectrum - - +  
- 
Good Special for children 
Larvae Broad spectrum - - -  Not relevant Special indications 
Hypochlorite 
Broad spectrum, effective 
against biofilms, bacterial 




- - - Good 
Antiseptic cleaning 
of acute and chronic 
wounds 
Silver ions Low activity + + +++ - ++ ++ Poor No first choice 
Fusidic acid 
Effective only against Gram- 
positives 
++ ? ++ ++ + ? Good Not needed 
Nitrofurazone Gaps + ? ++ ++ + + ? Obsolete 
Chlorhexidine Gaps ++ + + +6 - Possibly4 Good Not needed 
Hydrogen 
peroxide 




Continuation Table 1: Brief characterization of antiseptic agents (modified after Kramer et al. 2012, 2017) 
Active 
substance 




































































































Insufficient effective ? - ++ + (airborne)7  ? ? Obsolete 
Acetic acid Broad spectrum - - - - ? - Good 
Promising 
perspectives 
1  + in vitro    ++ clinically relevant 
2  + low   ++ moderate   +++ high 
3  - very low risk    + cause of contact eczemas in rare cases     ++ cause of contact eczemas in many cases (>1%) 
4  the degradation product 4-chloroaniline are even carcinogenic, but its release up to now is demonstrated only in the mouth cavity (Below et al. 2017) 
5  Anaphylactic reactions (n = 3 worldwide; Kautz et al. 2010, Creytens et al. 2014, Schroeder et al. 2014) 
6  Anaphylactic reactions (1:10.000 – 1:25.000 after usage perioperatively; Moka et al. 2015)  
7  Rudzki and Rebandel (2001) 
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2.4 Field of applications for antiseptics 
Antiseptics are needed to prevent and treat wound infections, especially when wounds 
are at increased risk of infection. Table 2 gives an overview of the risk factors for wound 
infection. 
Table 2: Risk factors for wound infection (modified after Dissemond et al. 2011) 
Wounds at particular risk of infection 
Exogenously increased risk of infection Endogenously and immunologically 
increased risk of infection 
Heavily contaminated wounds (gunshot, 
bite, traumatic wounds) 
Congenital immune defects 
Presence of foreign bodies Acquired immune defects 
Postsurgical wounds following 
procedures with high microbial 
contamination 
Immunosuppressive medication 
Specific pathogenicity and virulence of 
the pathogen present in the wound 
Diabetes mellitus 
Risk due to location (e.g. perineal 
surgery) 
Advanced age 
Environmental risks (e.g. occupational 
and lifestyle risks) 
Young age (premature infants, babies, 
infants) 





Blood flow problems 
Kidney diseases  
Obesity 
 
In 2011, the wound at risk score (W.A.R) was introduced as a practice oriented method 
to aid in deciding when to use antiseptics in order to prevent wound infections. 
 
Based on the risk factors, the W.A.R. score (Table 3) can be calculated, a score ≥ 3 
points represents a clinical indication for the administration of antiseptics. This is a 







Table 3: Classification for wounds at risk: the W.A.R. score (from Dissemond et al. 
2011) 
Risk class Risk definition (based on risk status 












a) Acquired immunosuppressive disease (e.g. 
diabetes mellitus) 
b) Acquired immune defect due to medical 
therapy such as cyclosporine, 
methotrexate, glucocorticoids or antibodies 
c) Solid tumor disease 
d) Systemic hematological disease 
e) Postsurgical wound healing disorder, which 
results in (unplanned) secondary healing 
f) Potentially heavily contaminated wounds 
(e.g. perineum, genitals) 
g) Problematic hygienic conditions related to 
social or occupational environment (e.g. 
agriculture, lorry driving) 
h) Patient age >80 years 
i) Young age of patient (premature infants, 
babies, infants) 
j) Wounds persisting for >1 year 
k) Wound dimensions of >10 cm2 
l) Chronic wounds of any etiology having a 
depth of >1.5 cm 
m) Extended inpatient status >3 weeks 
The presence of each 
risk factor 
adds 1 risk point 
(multiple responses are 
possible) 
the points are added 
Class 2 a) Severe acquired immune defects (e.g. HIV 
infection) 
b) Heavily contaminated acute wounds 
c) Bite, stab and gunshot wounds penetrating 
1.5 - 3.5 cm 
The presence of each 
risk factor 
adds 2 risk points 
(multiple responses are 
possible) 






a) Burn wounds with involvement of >15 % 
body surface area  
b) Wounds that have a direct connection to 
organs or functional structures (e.g. 
including joints) or which contain foreign 
material 
c) Severe congenital immune defects such as 
agammaglobulinemia, severe combined 
immune defects, etc. 
d) Bite, stab and gunshot wounds penetrating 
>3.5 cm 
e) contaminated soft tissue trauma 
The presence of each 
risk factor 
adds 3 risk points 
(multiple responses are 
possible) 
the points are added 
Finally, the risk factor points are added to obtain a total score. A score ≥ 3 points indicates 
the presence of a wound clinically at risk of infection and consequently represents a clinical 
indication for the administration of antiseptics. 
Regardless of this recommendation, other treatment indications may be present, which 
themselves require local antimicrobial treatment such as elimination of pathogens when 




3   Methods and Materials  
3.1 Safety and operating precautions 
All procedures followed the institution’s regulations and procedures for the handling of 
human or animal materials, which include, but are not limited to, tissues and tissue 
fluids. Universal laboratory precautions were followed, including the use of laboratory 
coats, eye protection and gloves (ICCVAM 2010).  
 
3.2 Materials 
The following materials were been used: 
• Vakzine Lohmann specific pathogen free eggs (VALO SPF, Lohmann GmbH 
Cuxhaven, Germany) 
• Small-motored breeder (Typ KMB F/2, Ehret GmbH Emmendingen, Germany) with 
an automatic rotating mechanism and automatic humidity regulation (at 37 + 1 °C 
und 55 + 7 % relative humidity) 
• Egg Candler (Powerflash, J. Hemel Brutgeräte GmbH & Co.KG Verl, Germany) 
• Scissors 
• Handheld digital microscope (model 44300, Celestron, Torrance, CA, U.S.A., up 
to 400x magnification), 
• Camera (Canon Power Shot G9) 
• Stop clock 
• Cold-light lamp 
• pH-meter 
• Thermometers 
• Tapered forceps and tweezers 
• Pipettes (300 μl) 
• 0.1 n NaOH in distilled sterile water (positive standard I) 
• 1% Sodium dodecyl sulfate (SDS) solution in distilled sterile water (positive 
standard II) 
• 0.9% NaCl solution in distilled sterile water 
• Polyethylene film 







The following antiseptics and formulations were tested: 
• Octenilin® wound irrigation (Schülke GmbH, Norderstedt, Germany): Active agent 
octenidine hydrochloride 0.05% (ingredients: Aqua valde purficata, glycerol, 
ethylhexylglycerol)  
• Octenidin 0.05% (Schülke GmbH, Norderstedt, Germany) in aqueous solution + D-
panthenol (Bayer Vital GmbH, Leverkusen) 1.34% + allantoin (Merck KGaA 
Darmstadt, Germany) 0.2%  
• Dermacyn® Wound care solution (SastoMed GmbH Georgsmarienhütte, 
Germany): Active agent NaOCl/HOCl (each 0.004%) 
• Granulox® spray (SastoMed GmbH Georgsmarienhütte, Germany): Active agent 
hemoglobin 10% (ingredients: phenoxyethanol 0.1%, sodium chloride 0.9%, N-
acetylcystein 0.5% in aqueous solution) 
• Furacin® sol 0.2% ointment (Riemser Arzneimittel AG Riems, Germany): Active 
agent nitrofural 0.2% 
• Polihexanide (Fagron Services BV, Uitgeest, Netherlands; Manufacturer Arch UK 
Biocides, UK) in Ringer solution (Fresenius Kabi GmbH Bad Homburg, Germany): 
Active agent polihexanide 0.04%  
• Polihexanide (Fagron Services BV, Uitgeest, Netherlands; Manufacturer: Arch UK 
Biocides, UK): 0.05% in Lipofundin® o/w emulsion (B. Braun Melsungen AG) 
(mixture of both components in the laboratory) 
• Braunovidon® ointment (B. Braun Melsungen AG, Germany): Active agent: 
Povidone iodine 10% 
• Flammazine® cream (Sinclair Pharma GmbH Frankfurt am Main, Germany): Active 
agent silver sulfadiazine 1% 
• Chlorhexidine digluconate 0.5% solution in sterile aqueous solution (mixture of 
both components in the laboratory) 
• Bepanthen® antiseptic wound cream (Bayer Vital GmbH, Leverkusen, Germany): 
Active agent chlorhexidine digluconate 0.5%, (ingredients: Dexpanthenol 5%) 
• Dexpanthenol 5% (Bayer Vital GmbH, Leverkusen, Germany) in sterile aqueous 
solution (mixture of both components in the laboratory) 
• Sodium thiocyanate (Fluka Chemie GmbH über Sigma-Aldrich GmbH, Steinheim, 
Germany, Germany): 0.698% solution in aqueous solution (mixture of both 
components in the laboratory) 
• Hydrogen peroxide (Fluka Chemie GmbH (Buchs, Switzerland über Sigma-Aldrich 
Chemie GmbH Steinheim, Germany): 0.5% in aqueous solution (mixture of both 
components in the laboratory) 
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• Hydrogen peroxide (Fluka Chemie GmbH Buchs, Switzerland über Sigma-Aldrich 
Chemie GmbH, Steinheim, Germany): 1.5% in aqueous solution (mixture of both 
components in the laboratory) 
• Hydrogen peroxide (Fluka Chemie GmbH Buchs, Switzerland über Sigma-Aldrich 
Chemie GmbH, Steinheim, Germany): 1.5% + sodium thiocyanate 0.698% in 
aqueous solution (mixture of both components in the laboratory 
 
0.1 n NaOH in distilled sterile water and 1% Sodium dodecyl sulfate (SDS) solution in 
distilled sterile water were tested as positive controls, 0.9% NaCl solution in distilled 
sterile water was tested as negative control. 
 
3.3 Study protocol 
This study used the test protocol used in Phase II of the German Validation Study for 
Replacement of the Draize Eye Test (Spielmann and Liebsch 1991). 
 
Incubation of eggs: 
• After the arrival of the eggs, they are placed in a warming box for 48 h at 15 °C (± 
1 °C). Before insertion into the box, the eggs are disinfected by a wipe soaked with 
70% v/v ethanol (produced in the pharmacy of the University of Greifswald, 
Germany). Additionally, the eggs are weighed and numbered. 
• As next step, the eggs are candled and discarded in case of defects. 
• Before incubation, the incubator's (KMB F/2, Ehret GmbH Emmendingen, 
Deutschland) reservoir was filled with water. The eggs were placed flat onto 
incubator trays in a 37.5 ± 1°C and 62 ± 7.5% rel. humidity, and were rotated 
automatically for 8 days to prevent the attachment of the embryo to one side of the 
egg.  
• The temperature of the incubator was controlled automatically, humidity and water 
level were checked manually every day. 
• The eggs were candled on the ninth day with Powerflash (J. Hemel Brutgeräte 
GmbH & Co.KG Verl, Germany), and nonviable eggs were discarded; then the 
fertilized eggs were placed in the incubator with the large end upward without 
rotation, thus ensuring accessibility to the chorioallantoic membrane. 







Preparation of eggs: 
• Each egg was candled before preparation to ensure that all are viable, a cold lamp 
was used to ensure optimal illumination of the chorioallantoic membrane. any 
nonviable egg was excluded. 
• In a fume cupboard, the air cell was marked using an Egg Candler and then the 
shell was removed off by the scissors. 
• The membrane was carefully moistened with 0.9% NaCl solution at 37 °C. 
• The eggs were placed in the incubator until they were ready for being tested. 
• Fresh standards and test substances were prepared (in the appropriate solvents) 
before each test cycle at room temperature. 
 
Test procedure and assessment: 
• The opened egg was taken out of the incubator, then the moistening solution (0.9% 
NaCl) was poured off, and carefully the membrane was removed (without injuring 
any underlying blood vessels) using tapered forceps. 
• A photo (Canon Power Shot G9 Camera) for the (CAM) was taken before adding 
the test substance. 
• 0.3 ml of each standard or test substance was applied onto the CAM. 
• The reactions on the CAM were observed over a period of 5 minutes, what was 
monitored is the appearance of: 
- Hemorrhage (bleeding). 
- Vascular lysis (blood vessel disintegration).  
- Coagulation (protein denaturation intra- and extravascular). 
• The time in seconds for each reaction to occur was recorded and then the irritation 




) × 5 + (
301−t(l)
300
) × 7 +  (
301−t(c)
300
) × 9 
 h = hemorrhage; l = vessel lysis; c = coagulation; t = start second 
• The mean of the irritation score (IS) for all the tested eggs was calculated. The IS 
encompasses values between 0 and 21. The effects of vascular irritation are 
measured semi-quantitatively and are differentiated in 4 (IS) ranges according to 
Spielmann (Marquardt et al. 2010):  
0 = no reaction (0.0 – 0.9) 
1 = slight reaction (1.0 – 4.9) 
2 = moderate reaction (5.0 – 8.9) 
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3 = severe reaction (9 – 21) 
• Another photo for the (CAM) was taken 5 minutes after adding the test substance. 
• After the exposure time of 5 minutes, the main reaction (either hemorrhage = 
bleeding; vascular lysis = blood vessel disintegration; or coagulation = protein 
denaturation intra- and extravascular) was recorded with reaction severity 
according to the following scheme: 
0 = No reaction 
1 = Slight reaction 
2 = Moderate reaction 
3 = Severe reaction 
• When the test substance was a cream, an ointment, or a colored solution that 
disabled the monitoring of the CAM and impedes calculating the IS, the test 
followed the following algorithm:  In case of cream or ointment, the cream or 
ointment was put on a plastic slide, the slide was applied onto the CAM for 5 
minutes and then removed. In case of solution, the solution was put onto the CAM 
to cover approximately half of its surface, and after 5 minutes, the solution was 
carefully removed using a sterilized tissue to absorb the solution, and then the main 
reaction (hemorrhage, lysis, coagulation) was recorded and scored according to 
the same previous scheme (see above).  
• The mean of the reaction severity after 5 min for all tested eggs was calculated. 
• Afterwards the eggs were covered with an adhesive polyethylene film and 
incubated for another 24 hours. The CAM of each egg was then re-evaluated to 
see which of the embryos remained alive after 24 hours. 
• Photos of the living embryos were taken after 24 hours.  
• At the end of the test the embryos were killed as quickly as possible (by placing 
the eggs into a freezer at -20 °C). 
 
Any shaking, unnecessary tilting, knocking and all other mechanical irritation of the 
eggs was avoided. 
 
Test scheme: 
The irritation score (IS) was determined for the two positive standards with two to three 
eggs at each day of the experiment. The test protocol specifies: The 1% SDS solution 
should give an IS of 10 ± 2, the 0.1 n NaOH solution an IS of 15 ± 3. 1% SDS should 
show hemorrhage and lysis within the first minute, whereas 0.1 n NaOH shows all 3 
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phenomena, first hemorrhage within several seconds, later coagulation and lysis at 
about 1 minute (Spielmann and Liebsch 1991). 
  
3.4 Experiment phases 
Tests were done in 3 phases (Table 4). In each round 90 eggs were tested, so the total 
number of eggs used in the experiments was 270. 64 eggs were excluded because 
they were nonviable, or broken, or the chorioallantoic membrane was severely injured 
during the experiment. 
 
Table 4: Experiment phases 
Round Experiment day Number of tested eggs 
First 1 30 
2 30 
3 30 
Second 4 45 
5 45 
Third  6 45 
7 45 
 
3.5 Contamination test 
After finishing the second phase of the experiment, it was noticed that the majority of 
the eggs died after 24h even though they were being incubated. Therefore, multiple 
samples (n = 6) of the surface of the CAM were taken using cotton swabs to check 
bacterial contamination and then: 
• The samples were spread on the surfaces of different blood agar dishes  
• Each Petri dish was labeled with the source of the sample 
• The Petri dishes were placed in a microbiological incubator for 48 h at 36 + 2 °C 
• Finally, the colony forming units (cfu) were recorded. 
  






3.6 Statistical analysis 
Statistical analysis was made and plots were calculated using SAS (Statistical Analysis 
Software, SAS Institute Inc., Cary, USA). Data (IS) were presented as mean with 
standard deviation and minimal and maximal value of IS. Descriptive statistics included 
median, 25th and 75th percentiles. The values were tested for normal distribution.  
 
The significances were tested in comparison to the controls 0.1 N NaOH resp. 1% SDS 
as well as between the different test groups. 
 
Statistical analysis was done using Graph Pad Prism Version 6.0. Descriptive statistics 
included mean, median, maximum, minimum, 25th and 0.75th percentiles and 
standard deviation. Normal distribution of the values was confirmed using D’Agostino-
Pearson omnibus K2 test. Significant differences were calculated with ordinary one-
way ANOVA followed by Dunnett's multiple comparisons test to compare test groups 
with positive control, 0.1 N NaOH or 1% SDS respectively, and by Tukey's multiple 





4   Results 
4.1 Irritation Scores in the HET-CAM 
In the negative controls with 0.9% NaCl in distilled sterile water no reaction was 
induced in any case within 5 minutes (Table 5); thus, the irritation score (IS) was zero. 
10 of 18 eggs died after 24 hours; on alive eggs (8 of 18) also no reaction was 
observed. 
 
Table 5: Results of negative control (0.9% NaCl solution in distilled sterile water) 
 
Day* Egg 
Time (s) for reaction to occur  
IS 
 
After 5 min  After 
24 













1 2 0 0 Died 
1 3 0 0 Alive 
2 4 0 0 Died 
2 5 0 0 Alive 
2 6 0 0 Died 
3 7 0 0 Alive 
3 8 0 0 Died 
4 9 0 0 Died 
4 10 0 0 Died 
4 11 0 0 Died 
5 12 0 0 Died 
5 13 0 0 Alive 
6 14 0 0 Alive 
6 15 0 0 Alive 
6 16 0 0 Died 
7 17 0 0 Died 
7 18 0 0 Alive 
Number of eggs tested: 18  
Mean of irritation score (IS): 0 
Standard deviation of irritation score (IS): 0 
Irritation score (IS) range according to Spielmann: No reaction 
Most common main reaction after 5 minutes: No reaction 
Mean of the reaction severity after 5 minutes: 0 
Percentage of alive eggs after 24 hours: 44% 




In figure 1, CAM is presented before application of the control solution, the blood 
vessels are normal without hemorrhage, lysis or coagulation. The CAM in figure 2 after 




Figure 1: CAM before adding negative control (0.9% NaCl in distilled sterile water) 
 
 
Figure 2: No reaction is noticeable on CAM 5 minutes after applying negative control 




In table 6, the reactions of each egg (n = 18) of positive controls (0.1 n NaOH in dist. 
sterile water) are presented. The mean of IS was 15.3, the most common main reaction 
after 5 minutes was hemorrhage, no egg survived after 24 hours. The findings 
according to the test protocol: 0.1 n NaOH in distilled water should give an IS of 15 ± 
3 and should show all 3 phenomena hemorrhage, coagulation and lysis.  
 
Table 6: Results of positive control with 0.1 n NaOH in distilled sterile water  
Day Egg 
Time (s) for reaction to occur 
IS 
 
After 5 min  After 
24 






1 1 13 150 34 16.3 Hemorrhage 3 Died 
1 2 16 150 301 8.2 Hemorrhage 2 Died 
1 3 9 130 107 14.6 Hemorrhage 2 Died 
2 4 9 100 137 14.4 Hemorrhage 3 Died 
2 5 11 120 132 14.1 Hemorrhage 3 Died 
2 6 19 75 110 15.7 Hemorrhage 3 Died 
3 7 6 148 90 14.8 Hemorrhage 3 Died 
3 8 17 133 110 14.3 Hemorrhage 3 Died 
4 9 10 200 50 14.7 Hemorrhage 3 Died 
4 10 9 90 55 17.1 Hemorrhage 3 Died 
5 11 11 77 53 17.5 Hemorrhage 3 Died 
5 12 6 60 66 17.5 Hemorrhage 3 Died 
5 13 9 44 86 17.3 Hemorrhage 3 Died 
6 14 13 70 150 14.7 Hemorrhage 3 Died 
7 15 16 16 140 16.2 Hemorrhage 3 Died 
7 16 15 43 120 16.2 Hemorrhage 3 Died 
7 17 15 50 130 15.7 Hemorrhage 3 Died 
7 18 15 52 135 15.5 Hemorrhage 3 Died 
Number of eggs tested: 18  
Mean of irritation score (IS): 15.3 
Standard deviation of irritation score (IS): 2.1 
Irritation score (IS) range according to Spielmann: Severe reaction 
Most common main reaction after 5 minutes: Hemorrhage 
Mean of the reaction severity after 5 minutes: 3 
Percentage of alive eggs after 24 hours: 0% 
 
In figures 3 and 4, a typical example of CAM before and after application of 0.1 n NaOH 









Figure 4: CAM shows hemorrhage, lysis and coagulation 5 minutes after adding 0.1 n 






According to the test protocol, 1% SDS should give an IS of 10 ± 2 and should show 
hemorrhage and lysis. The mean of IS at the experiment was 10.0, and all the 18 eggs 
show hemorrhage and lysis (Table 7). 
 
Table 7: Results of positive control with 1% SDS solution in distilled sterile water 
Day Egg 
Time (s) for reaction to occur 
IS 
 
After 5 minutes  After 
24 





1 1 21 81 No reaction 9.8 Hemorrhage 1 Died 
1 2 25 90 No reaction 9.5 Lysis 2 Died 
1 3 90 245 No reaction 4.8 Hemorrhage 1 Died 
2 4 21 112 No reaction 9 Lysis   2 Died 
2 5 65 123 No reaction 8 Lysis 1 Died 
2 6 85 129 No reaction 7.6 Lysis 2 Died 
3 7 27 160 80 14.4 Hemorrhage 1 Died 
3 8 50 107 No reaction 8.7 Lysis 1 Died 
4 9 22 155 No reaction 8 Hemorrhage 2 Died 
4 10 43 205 102 12.5 Lysis 2 Died 
5 11 34 90 No reaction 9.3 Lysis 2 Died 
5 12 26 79 125 15 Lysis 2 Died 
5 13 33 67 No reaction 9.9 Hemorrhage 1 Died 
6 14 22 53 No reaction 10.4 Lysis 2 Died 
7 15 20 30 No reaction 11 Lysis 2 Died 
7 16 23 40 No reaction 10.7 Lysis 2 Died 
7 17 20 60 No reaction 10.3 Lysis 2 Died 
7 18 15 40 No reaction 10.8 Lysis 2 Died 
Number of eggs tested: 18  
Mean of irritation score (IS): 10.0 
Standard deviation of irritation score (IS): 2.39 
Irritation score (IS) range according to Spielmann: Severe reaction 
Most common main reaction after 5 minutes: Lysis 
Mean of the reaction severity after 5 minutes: 1.66 




Before application of 1% SDS solution, the CAM was normal without any deviation 
(Figure 5). After application of 1% SDS solution, the CAM reacts with hemorrhage and 
lysis (Figure 6). 
 
 




Figure 6: CAM shows hemorrhage and lysis 5 minutes after adding 1% SDS solution 




The wound irrigation solution Octenilin® induced severe reactions. After 5 minutes, 6 
eggs reacted with coagulation of severity 2, 3 eggs with lysis of severity 1 (Table 8). 
 
Table 8: Irritation Potency of Octenilin®  
Day Egg 
Time (s) for reaction to occur 
IS 
 
After 5 minutes  After 
24 





1 1 150 
No 
reaction 
25 10.7 Coagulation 2 Died 
1 2 250 280 15 9.9 Coagulation 2 Died 
1 3 153 205 29 12.8 Coagulation 2 Died 
2 4 110 44 89 15.5 Coagulation 2 Died 
2 5 No reaction 200 93 8.5 Coagulation 2 Died 
2 6 67 160 105 13 Coagulation 2 Died 
3 7 No reaction 166 180 6.7 Lysis 1 Died 
3 8 No reaction 175 240 4.7 Lysis 1 Died 
7 9 50 50 No reaction 10 Lysis 1 Died 
Number of eggs tested: 9  
Mean of irritation score (IS): 10.2 
Standard deviation of irritation score (IS): 3.33 
Irritation score (IS) range according to Spielmann: Severe reaction 
Most common main reaction after 5 minutes: Coagulation 
Mean of the reaction severity after 5 minutes: 1.66 
Percentage of alive eggs after 24 hours: 0% 
 
In figure 7, the CAM before application of Octenilin® is seen; 5 minutes after application 
















The combination of octenidine with dexpanthenol and allantoin showed all reaction 
types, this means hemorrhage, coagulation and lysis with severity ranged between 1 
and 3. The mean of IS was 8.7.  
 
Table 9: Irritation potency of octenidine 0.05% in aqueous solution + dexanthenol 
1.34% + allantoin  
Day Egg 
Time (s) for reaction to occur 
IS 
 
After 5 minutes  After 
24 





5 1 164 140 No reaction 6 Hemorrhage 1 Died 
5 2 154 110 120 12.3 Coagulation 1 Died 
5 3 215 126 No reaction 5.5 Lysis 1 Died 
5 4 120 166 No reaction 6.1 Hemorrhage 1 Died 
7 5 60 34 No reaction 10.2 Lysis 2 Died 
7 6 105 35 No reaction 9.4 Lysis 3 Died 
7 7 73 39 No reaction 9.9 Lysis 3 Died 
7 8 94 38 No reaction 9.5 Lysis 2 Died 
7 9 123 27 No reaction 9.3 Lysis 1 Died 
Number of eggs tested: 9 eggs 
Mean of irritation score (IS): 8.7 
Standard deviation of irritation score (IS): 2.3 
Irritation score (IS) range according to Spielmann: Moderate reaction 
Most common main reaction after 5 minutes: Lysis 
Mean of the reaction severity after 5 minutes: 1.66 
Percentage of alive eggs after 24 hours: 0% 
 
Figure 9 shows the CAM before the application of the mixture of octenidine with 
addition of dexpanthenol and allantoin. Figure 10 gives an example of moderate 





Figure 9: CAM before adding octenidine 0.05% + dexpanthenol 1.34% + allantoin 




Figure 10: CAM shows hemorrhage and lysis 5 minutes after adding octenidine 







After application of Dermacyn® Wound care solution, 9 eggs showed no reaction. The 
other 8 eggs reacted within 5 minutes with lysis of severity 1 or 2 (Table 10). The mean 
of IS was 1.1, the IS range was considered as “slight reaction”. 
 
Table 10: Irritation Potency of Dermacyn® Wound care solution 
Day Egg 
Time (s) for reaction to occur 
IS 
 











1 1 No reaction 220 No reaction 1.8 Lysis 1 Died 
1 2 No reaction 285 No reaction 0.3 Lysis 1 Alive 
1 3 No reaction No reaction No reaction 0 No reaction 0 Alive 
1 4 No reaction 156 No reaction 3.3 No reaction 0 Died 
2 5 No reaction 280 No reaction 0.4 Lysis 1 Died 
2 6 No reaction No reaction No reaction 0 No reaction 0 Alive 
3 7 No reaction No reaction No reaction 0 No reaction 0 Alive 
3 8 No reaction No reaction No reaction 0 No reaction 0 Alive 
6 9 No reaction 260 No reaction 0.9 Lysis 1 Alive 
6 10 No reaction No reaction No reaction 0 No reaction 0 Alive 
6 11 No reaction No reaction No reaction 0 No reaction 0 Died 
6 12 No reaction No reaction No reaction 0 No reaction 0 Alive 
6 13 No reaction 200 No reaction 2.3 Lysis 1 Alive 
7 14 No reaction 230 No reaction 1.6 Lysis 1 Died 
7 15 No reaction 90 No reaction 4.9 Lysis 1 Died 
7 16 No reaction No reaction No reaction 0 No reaction 0 Alive 
7 17 No reaction 150 No reaction 3.5 Lysis 2 Died 
Number of eggs tested: 17  
Mean of irritation score (IS): 1.1 
Standard deviation of irritation score (IS): 1.54 
Irritation score (IS) range according to Spielmann: Slight reaction 
Most common main reaction after 5 minutes: Lysis 
Mean of the reaction severity after 5 minutes: 1  
Percentage of alive eggs after 24 hours: 59% 
 
The CAM before application of Dermacyn® (Figure 11) did not differ in 9 eggs from the 
clinical picture after application. In figure 12 a CAM after application of Dermacyn® 









Figure 12: CAM shows no reaction 5 minutes after adding Dermacyn®  






Although Granulox® spray is red, it allows the monitoring of the reactions happening 
on the CAM. Of 9 eggs, no CAM showed any reaction (Table 11). After 24 hours, no 
egg was alive. 
 
Table 11: Irritation potency of Granulox® spray 
Day Egg 
Time (s) for reaction to occur 
IS 
 
After 5 minutes  After 
24 





1 1 No reaction 
No 
reaction 




1 2 No reaction 
No 
reaction 




1 3 No reaction 
No 
reaction 




2 4 No reaction 
No 
reaction 




2 5 No reaction 
No 
reaction 




2 6 No reaction 
No 
reaction 




3 7 No reaction 
No 
reaction 




3 8 No reaction 
No 
reaction 




7 9 No reaction 
No 
reaction 




Number of eggs tested: 9 eggs 
Mean of irritation score (IS): 0 
Standard deviation of irritation score (IS): 0 
Irritation score (IS) range according to Spielmann: No reaction 
Most common main reaction after 5 minutes: No reaction 
Mean of the reaction severity after 5 minutes: 0 
Percentage of alive eggs after 24 hours: 0% 
 
One example of a CAM before (Figure 13) and after application of Granulox® spray 



















Furacin® ointment is a yellow opaque ointment, therefore calculating of IS was 
impossible. The test was done as follows: The ointment was put on a plastic slide, then 
the slide was turned on the CAM for 5 minutes and thereafter the slide was removed. 
Only one egg showed no reaction, 7 eggs showed hemorrhage with severity 1 and one 
egg showed coagulation with severity 2 (Table 12). 
 
Table 12: Irritation potency of Furacin® ointment after 5 minutes 
Day Egg 
Because of the yellow color of the 
ointment, evaluation of test 
reactions was only possible after 




After 5 minutes  
After 24 





















No reaction 0 Died 
1 2 Coagulation 2 Died 
1 3 Hemorrhage 1 Died 
2 4 Hemorrhage 1 Died 
2 5 Hemorrhage 1 Died 
2 6 Hemorrhage 1 Died 
3 7 Hemorrhage 1 Died 
3 8 Hemorrhage 1 Died 
3 9 Hemorrhage 1 Died 
Number of eggs tested: 9  
Mean of irritation score (IS): Cannot be calculated 
Irritation score (IS) range according to Spielmann: Cannot be known 
Most common main reaction after 5 minutes: Hemorrhage 
Mean of the reaction severity after 5 minutes: 1 
Percentage of alive eggs after 24 hours: 0% 
 
The difference between normal CAM before application of Furacin® ointment (Figure 

















Figure 16: CAM shows hemorrhage 5 minutes after applying Furacin® ointment and 





Responding to polihexanide 0.04% in Ringer solution, 2 CAMs reacted with lysis 
severity 2, the other 7 CAMs showed no reaction. 2 eggs were alive after 24 hours 
(Table 13). 
 
Table 13: Irritation potency of polihexanide 0.04% in Ringer solution 
Day Egg 
Time (s) for reaction to occur 
IS 
 










2 1 No reaction 82 No reaction 5.1 Lysis 2 Died 
2 2 No reaction 180 No reaction 2.8 Lysis 2 Died 
1 3 No reaction No reaction No reaction 0 No reaction 0 Alive 
2 4 No reaction No reaction No reaction 0 No reaction 0 Died 
3 5 No reaction No reaction No reaction 0 No reaction 0 Died 
3 6 No reaction No reaction No reaction 0 No reaction 0 Alive 
3 7 No reaction No reaction No reaction 0 No reaction 0 Died 
3 8 No reaction No reaction No reaction 0 No reaction 0 Died 
3 9 No reaction No reaction No reaction 0 No reaction 0 Died 
Number of eggs tested: 9  
Mean of irritation score (IS): 0.9 
Standard deviation of irritation score (IS): 1.83 
Irritation score (IS) range according to Spielmann: No reaction 
Most common main reaction after 5 minutes: Lysis 
Mean of the reaction severity after 5 minutes: 0.22 
Percentage of alive eggs after 24 hours: 22% 
 
Figure 17 shows the CAM before application of polihexanide solution; figure 18 shows 


















Figure 18: CAM shows Lysis 5 minutes after adding polihexanide 0.04%  







Lipofundin is a white non-opaque emulsion that made the monitoring of the CAM and 
calculating the IS impossible, so the test was done as follows: The solution was put 
onto the CAM to cover approximately half of its surface (Figure 20), after 5 minutes, 
the solution carefully was rinsed off using a sterilized tissue to absorb out test material 
(Figure 21), then the main reaction (hemorrhage, lysis, coagulation) was recorded, and 
the main reaction was scored (Table 14). 
 
Table 14: Irritation potency of polihexanide 0.05% in Lipofundin® o/w emulsion 
Day Egg 
Because of the white color of the 
emulsion, evaluation of test reactions 
was only possible after removing the 
emulsion 5 minutes after application 
IS 
 
After 5 minutes  
After 24 





















No reaction 0 Died 
4 2 No reaction 0 Died 
4 3 No reaction 0 Died 
5 4 No reaction 0 Died 
5 5 No reaction 0 Died 
6 6 No reaction 0 Died 
6 7 No reaction 0 Alive 
6 8 No reaction 0 Alive 
7 9 No reaction 0 Died 
Number of eggs tested: 9  
Mean of the irritation score (IS): Cannot be calculated 
Irritation score (IS) range according to Spielmann: Cannot be known 
Most common main reaction after 5 minutes: No reaction 
Mean of the reaction severity after 5 minutes: 0 
Percentage of alive eggs after 24 hours: 22% 
 
 
In figure 19, the CAM is shown before the application of polihexanide 0.05% in 
Lipofundin®. In figure 20 the reaction of the CAM is shown one minute after applying. 
In figure 21 the CAM shows no reaction 5 minutes after applying the emulsion, 















Figure 21: CAM shows no reaction 5 minutes after applying polihexanide 0.05% in 
Lipofundin®; the hemorrhage was caused by the sterilized tissue which was used to 
absorb the test material 
 
Braunovidon® is a brown ointment that made the monitoring of CAM and calculating 
the IS impossible, so the test was done as follows: The ointment was put on a plastic 
slide, then the slide was turned on the CAM for 5 minutes and then it was removed, 
thereafter the main reaction (hemorrhage, lysis, coagulation) was recorded and 
scored. 4 eggs did not show any reaction, 3 showed hemorrhage and 3 showed lysis 

















Table 15: Irritation potency of Braunovidon® ointment after 5 minutes 
Day Egg 
Because of the brown color of the 
ointment, evaluation of test reactions 
was only possible after removing the 
ointment 5 minutes after application 
IS 
 

























No reaction 0 Died 
4 2 Hemorrhage 1 Died 
4 3 Hemorrhage 1 Died 
5 4 No reaction 0 Died 
6 5 Hemorrhage 1 Died 
6 6 No reaction 0 Died 
6 7 No reaction 0 Died 
6 8 Lysis 1 Died 
7 9 Lysis 1 Died 
Number of eggs tested: 9 eggs 
Mean of irritation score (IS): Cannot be calculated 
Irritation score (IS) range according to Spielmann: Cannot be known 
Most common main reaction after 5 minutes: Hemorrhage 
Mean of the reaction severity after 5 minutes: 0.55 
Percentage of alive eggs after 24 hours: 0% 
 
Figure 23 shows hemorrhage 5 minutes after applying Braunovidon® ointment. For 

















Flammazine® cream is a white cream that made the monitoring of CAM and calculating 
the IS impossible, hence the cream was put on a plastic slide, which was turned on 
the CAM for 5 minutes and then it was removed. Thereafter the main reaction 
(hemorrhage, lysis, coagulation) was recorded and scored. 8 eggs did not show any 
reaction while only one showed lysis severity 1 (Table 16).   
 
Table 16: Irritation potency of Flammazine® cream after 5 minutes 
Day Egg 
Because of the white color of the 
cream, evaluation of test reactions 
was only possible after removing 




After 5 minutes  
After 24 




















No reaction 0 Died 
4 2 No reaction 0 Died 
4 3 No reaction 0 Died 
5 4 No reaction 0 Died 
6 5 No reaction 0 Died 
6 6 No reaction 0 Died 
6 7 No reaction 0 Died 
6 8 No reaction 0 Died 
7 9 Lysis 1 Died 
Number of eggs tested: 9 eggs 
Mean of irritation score (IS): Cannot be calculated 
Irritation score (IS) range according to Spielmann: Cannot be known 
Most common main reaction after 5 minutes: Lysis 
Mean of the reaction severity after 5 minutes: 0.11 
Percentage of alive eggs after 24 hours: 0% 
 
In figures 24 and 25 the CAM is shown before and after 5 min of Flammazine® 
















Chlorhexidine digluconate induced severe reactions. The main reaction to be noticed 
was coagulation (6 eggs); 3 eggs showed lysis. All the eggs died after 24 hours (Table 
17). 
 
Table 17: Irritation potency of chlorhexidine digluconate 0.5% solution 
Day Egg 
Time (s) for reaction to occur 
IS 
 
After 5 minutes After 
24 





4 1 90 214 110 11.2 Coagulation 2 Died 
4 2 301 60 77 12.3 Coagulation 2 Died 
5 3 301 120 100 10.2 Coagulation 2 Died 
5 4 301 70 301 5.3 Lysis 1 Died 
5 5 200 301 220 4.1 Coagulation 1 Died 
6 6 301 210 301 2.1 Lysis 1 Died 
7 7 94 22 301 9.9 Lysis 2 Died 
7 8 85 32 120 15.3 Coagulation 2 Died 
7 9 80 30 150 14.5 Coagulation 2 Died 
Number of eggs tested: 9  
Mean of irritation score (IS): 9.4 
Standard deviation of irritation score (IS): 4.63 
Irritation score (IS) range according to Spielmann: Severe reaction 
Most common main reaction after 5 minutes: Coagulation 
Mean of the reaction severity after 5 minutes: 1.66 
Percentage of alive eggs after 24 hours: 0% 
 
Figure 27 presents lysis after application of 0.5% chlorhexidine digluconate solution. 










Figure 27: CAM shows lysis 5 minutes after adding chlorhexidine digluconate  






Bepanthen® Cream is a white cream that made the monitoring of CAM and calculating 
the IS impossible, so the cream was put on a plastic slide which was turned on the 
CAM for 5 minutes, thereafter the slide was removed and the main reaction 
(hemorrhage, lysis, coagulation) was recorded and scored. 3 CAMs showed 
hemorrhage severity 1. The other six did not show any reaction (Table18). 
 
Table 18: Irritation potency for Bepanthen® cream after 5 minutes 
Day Egg 
Because of the white color of the 
cream, evaluation of test reactions was 
only possible after removing the cream 
5 minutes after application 
IS 
 

























No reaction 0 Died 
4 2 No reaction 0 Died 
4 3 No reaction 0 Died 
5 4 No reaction 0 Died 
6 5 Hemorrhage 1 Died 
6 6 Hemorrhage 1 Died 
6 7 No reaction 0 Died 
6 8 Hemorrhage 1 Died 
7 9 No reaction 0 Died 
Number of eggs tested: 9 eggs 
Mean of irritation score (IS): Cannot be calculated 
Irritation score (IS) range according to Spielmann: Cannot be known 
Most common main reaction after 5 minutes: Hemorrhage 
Mean of the reaction severity after 5 minutes: 0.33 
Percentage of alive eggs after 24 hours: 0% 
 
In figures 28 and 29 the CAM is shown before and after application of Bepanthen® 

















Dexpanthenol in 5% solution was tolerated without any reaction of the CAM (Table 
19). All eggs were died after 24 hours. 
 
Table 19: Irritation potency of dexpanthenol 5% solution 
Day Egg 
Time (s) for reaction to occur 
IS 
 










4 1 No reaction No reaction No reaction 0 No reaction 0 Died 
4 2 No reaction No reaction No reaction 0 No reaction 0 Died 
4 3 No reaction No reaction No reaction 0 No reaction 0 Died 
5 4 No reaction No reaction No reaction 0 No reaction 0 Died 
5 5 No reaction No reaction No reaction 0 No reaction 0 Died 
6 6 No reaction No reaction No reaction 0 No reaction 0 Died 
6 7 No reaction No reaction No reaction 0 No reaction 0 Died 
6 8 No reaction No reaction No reaction 0 No reaction 0 Died 
7 9 No reaction No reaction No reaction 0 No reaction 0 Died 
Number of eggs tested: 9  
Mean of irritation score (IS): 0 
Standard deviation of irritation score (IS): 0 
Irritation score (IS) range according to Spielmann: No reaction 
Most common main reaction after 5 minutes: No reaction 
Mean of the reaction severity after 5 minutes: 0 
Percentage of alive eggs after 24 hours: 0% 
 
Between the appearance of CAM before application of 5% dexpanthenol (Figure 30) 









Figure 31: CAM showed no reaction 5 minutes after adding dexpanthenol  







After application of 0.698% sodium thiocyanate, 4 eggs showed lysis with severity 1, 
the other 5 eggs did not show any reaction (Table 20). The classification for IS was 
“slight reaction”. 
 
Table 20: Irritation potency of sodium thiocyanate 0.698% solution 
Day Egg 
Time (s) for reaction to occur 
IS 
 










4 1 No reaction 105 No reaction 4.5 Lysis 1 Died 
4 2 No reaction 95 No reaction 4.8 Lysis 1 Died 
5 3 No reaction 134 No reaction 3.8 Lysis 1 Died 
5 4 No reaction No reaction No reaction 0 No reaction 0 Died 
5 5 No reaction No reaction No reaction 0 No reaction 0 Alive 
6 6 No reaction No reaction No reaction 0 No reaction 0 Alive 
7 7 No reaction No reaction No reaction 0 No reaction 0 Died 
7 8 No reaction No reaction No reaction 0 No reaction 0 Died 
7 9 No reaction 57 No reaction 5.6 Lysis 1 Died 
Number of eggs tested: 9  
Mean of the irritation score (IS): 2.1 
Standard deviation of irritation score (IS): 2.51 
Irritation score (IS) range according to Spielmann: Slight reaction 
Most common main reaction after 5 minutes: Lysis 
Mean of the reaction severity after 5 minutes: 0.33 
Percentage of alive eggs after 24 hours: 22% 
 
Figure 32 shows the CAM before application of 0.698% sodium thiocyanate, figure 33 






Figure 32: CAM before adding 0.698% sodium thiocyanate solution  
 
 








After application of 0.5% hydrogen peroxide, all 9 eggs showed lysis, the severity 
ranges between 1 and 3 (Table 21). The time after beginning of lysis ranged between 
30 and 155 seconds. 
 
Table 21: Irritation potency of 0.5% hydrogen peroxide  
Day Egg 
Time (s) for reaction to occur 
IS 
 
After 5 minutes After 
24 





4 1 No reaction 30 No reaction 6.3 Lysis 2 Died 
4 2 No reaction 55 No reaction 5.7 Lysis 1 Died 
4 3 No reaction 120 No reaction 4.2 Lysis 2 Died 
5 4 No reaction 155 No reaction 3.4 Lysis 1 Died 
5 5 No reaction 54 No reaction 5.7 Lysis 2 Died 
6 6 No reaction 31 No reaction 6.3 Lysis 3 Died 
6 7 No reaction 50 No reaction 5.8 Lysis 3 Died 
6 8 No reaction 47 No reaction 5.9 Lysis 3 Died 
7 9 No reaction 30 No reaction 6.3 Lysis 3 Died 
Number of eggs tested: 9  
Mean of irritation score (IS): 5.5 
Standard deviation of irritation score (IS): 1.02 
Irritation score (IS) range according to Spielmann: Moderate reaction 
Most common main reaction after 5 minutes: Lysis 
Mean of the reaction severity after 5 minutes: 2.2 
Percentage of alive eggs after 24 hours: 0% 
 
In seven eggs, 30-60 seconds after adding 0.5% hydrogen peroxide, bubbles 
appeared on the surface of the CAM (Figure 35). Figure 34 shows the CAM before 









Figure 35: CAM shows lysis and bubbles 5 minutes after adding 0.5%  







In the nine eggs, 10 seconds after adding 1.5% hydrogen peroxide solution, bubbles 
appeared on the surface of the CAM. After 5 minutes, all CAMs developed lysis of 
severity 2 or 3 (Table 22). After 24 hours, all eggs died. 
 
Table 22: Irritation potency of 1.5% hydrogen peroxide solution 
Day Egg 
Time (s) for reaction to occur 
IS 
 
After 5 minutes After 
24 





4 1 No reaction 89 No reaction 4.9 Lysis 3 Died 
4 2 No reaction 10 No reaction 6.7 Lysis 3 Died 
5 3 No reaction 50 No reaction 5.8 Lysis 3 Died 
5 4 No reaction 28 No reaction 6.3 Lysis 3 Died 
5 5 No reaction 60 No reaction 5.6 Lysis 2 Died 
6 6 No reaction 27 No reaction 6.3 Lysis 2 Died 
6 7 No reaction 37 No reaction 6.1 Lysis 3 Died 
7 8 No reaction 22 No reaction 6.5 Lysis 3 Died 
7 9 No reaction 22 No reaction 6.5 Lysis 3 Died 
Number of eggs tested: 9  
Mean of irritation score (IS): 6.1 
Standard deviation of irritation score (IS): 0.56 
Irritation score (IS) range according to Spielmann: Moderate reaction 
Most common main reaction after 5 minutes: Lysis 
Mean of the reaction severity after 5 minutes: 2.77 
Percentage of alive eggs after 24 hours: 0% 
 
While the CAM of all eggs was normal before the application of hydrogen peroxide 










Figure 37: CAM shows lysis 5 minutes after adding 1.5% hydrogen peroxide, bubbles 






After 5 minutes of applying 1.5% hydrogen peroxide and 0.698% sodium thiocyanate, 
one egg was without any reaction, 5 eggs showed lysis up to severity 3, 2 eggs showed 
coagulation (Table 23). 
 
Table 23: Irritation potency of the combination of 1.5% hydrogen peroxide and 0.698% 
sodium thiocyanate  
Day Egg 
Time (s) for reaction to occur 
IS 
 











5 1 No reaction 250 No reaction 1.1 Lysis 1 Died 
5 2 No reaction No reaction No reaction 0 No reaction 0 Died 
5 3 No reaction No reaction 300 0.03 Coagulation 1 Died 
5 4 No reaction No reaction 255 1.3 Coagulation 1 Died 
5 5 No reaction No reaction No reaction 0 No reaction 0 Died 
6 6 No reaction 106 No reaction 4.5 Lysis 1 Died 
6 7 No reaction 42 No reaction 6 Lysis 1 Died 
7 8 No reaction 28 No reaction 6.3 Lysis 2 Died 
7 9 No reaction 130 No reaction 3.9 Lysis 3 Died 
Number of eggs tested: 9  
Mean of irritation score (IS): 2.6 
Standard deviation of irritation score (IS): 2.61 
Irritation score (IS) range according to Spielmann: Slight reaction 
Most common main reaction after 5 minutes: Lysis 
Mean of the reaction severity after 5 minutes: 1.1 
Percentage of alive eggs after 24 hours: 0% 
 
In seven eggs, 10 seconds after adding the combination of hydrogen peroxide 1.5% 
and sodium thiocyanate 0.698%, the vessels of the CAM became black in color (Figure 
39). In one egg, 10 seconds after adding the mixture, bubbles appeared on the surface 









Figure 39: CAM shows lysis and vessels of the CAM became black in color after 






4.2 Statistic evaluation of the irritation scores 
The results of descriptive statistics are summarized in table 24. The mean IS for the 
positive controls were 10.0 ± 2.39 for 1% SDS and 15.3 ± 2.10 for 0.1 N NaOH. The 
mean for the negative control was 0.  After applying test substances, the highest 
means of IS were found for Octenilin® (10.2 ± 3.33) and 0.5% Chlorhexidine 
digluconate (9.4 ± 4.63). The IS decreased when the following test substances were 
used: 0.05% Octenidin + 1.34% dexpanthenol + 0.2% allantoin (8.7 ± 2.3), 1.5% H2O2 
(6.1 ± 0.56), 0.5% H2O2 (5.5 ± 1.02), 1.5% H2O2 + 0.698% NaSCN (2.6 ± 2.61), 0.698% 
NaSCN (2.1 ± 2.51), Dermacyn® (1.1 ± 1.54), 0.004% polihexanide in Ringer solution 
(0.9 ± 1.83), 5% dexpanthenol (0 ± 0), and Granulox® spray (0 ± 0). 
 
The IS could not be calculated for the other five test substances, Polihexanide 0.05% 
in Lipofundin®, Flammazine® cream, Bepanthen® cream, Braunovidon® ointment and 












Percentile Max Mean 
Std. 
Deviatio
n IS range 














0.9% NaCl solution in dist.  water 18 0.0 0.00 0.0 0.00 0.0 0.0 0.00 No reaction No reaction 0.00 44 
1% SDS (positive standard) 18 4.8 8.53 9.9 10.85 15.0 10.0 2.39 Severe reaction Lysis 1.64 0 
0.1 n NaOH (positive standard) 18 8.2 14.55 15.6 16.50 17.5 15.3 2.10 Severe reaction Hemorrhage 3.00 0 
Test substance in which IS can be calculated 
spray ®Granulox 9 0.0 0.00 0.0 0.00 0.0 0.0 0.00 No reaction No reaction 0.00 0 
5% Dexpanthenol 9 0.0 0.00 0.0 0.00 0.0 0.0 0.00 No reaction No reaction 0.00 0 
0.04% Polihexanide in Ringer 
solution 
9 0.0 0.00 0.0 1.40 5.1 0.9 1.83 No reaction Lysis 0.22 22 
wound care ®Dermacyn 17 0.0 0.00 0.3 2.05 4.9 1.1 1.54 Slight reaction Lysis 1.00 59 
0.698% NaSCN 9 0.0 0.00 0.0 4.65 5.6 2.1 2.51 Slight reaction Lysis 0.33 22 
NaSCN %+ 0.6982O2% H1.5 9 0.0 0.02 1.3 5.25 6.3 2.6 2.61 Slight reaction Lysis 1.10 0 
2O2% H0.5 9 3.4 4.95 5.8 6.30 6.3 5.5 1.02 Moderate reaction Lysis 2.20 0 
2O2% H1.5 9 4.9 5.70 6.3 6.50 6.7 6.1 0.56 Moderate reaction Lysis 2.77 0 
0.05% OCT + 1.34% 
dexpanthenol + 0.2% allantoin 
9 5.5 6.05 9.4 10.05 12.3 8.7 2.30 Moderate reaction Lysis 1.66 0 
0.5% Chlorhexidine digluconate 9 2.1 4.70 10.2 13.40 15.3 9.4 4.63 Severe reaction Coagulation 1.66 0 
wound irrigation  ®Octenilin
solution 
9 4.7 7.60 10.0 12.90 15.5 10.2 3.33 Severe reaction Coagulation 1.62 0 
63 
 
As shown in figure 40, the IS using the positive control 0.1 n NaOH was significant higher 
compared to the IS of test substances and the other positive control 1% SDS (P<0.0001). 
The score after 1% SDS application was significant higher compared to 1.5% and 0.5% 
H2O2, 1.5% H2O2 + 0.698% NaSCN, 0.698% NaSCN, Dermacyn®, 0.004% polihexanide 
in Ringer solution, 5% dexpanthenol, and Granulox® spray. In contrast, the IS of 
Octenilin®, 0.5% chlorhexidine digluconate and 0.05% octenidine+ 1.34% dexpanthenol 
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Figure 40: Irritation Scores of test substances compared to positive controls 
1**** P<0.0001 compared to 0.1 N NaOH; 2**** P=0.0005 und ****P<0.0001 compared to 1% SDS 
 
 
While the statistical analysis of the IS for the tested creams could not be calculated, for 
the other test substances differences were partly significant (Table 25). The formulations 
on basis of hypochlorite and polihexanide as well as the hemoglobin spray were 
significantly better tolerable than the octenidine and chlorhexidine based formulations 
and hydrogen peroxide in both tested concentrations. While 0.04% polihexanide in 
Ringer solution was significantly more tolerable than 1.5% H2O2, the difference was 
negated via the addition of 0.698% NaSCN to the H2O2 (p>0.999). By adding 
dexpanthenol and allantoin, the irritant of effect of octenidine was decreased slightly (p 
0.279). Dermacyn, 0.04% polihexanide in Ringer solution and Granulox did not 
significantly differ in irritative effect (each p>0.99). The IS of Octenilin® and 0.5% 





Table 25: Significant differences between test substances 
Comparison 
Mean 





Significant differences between test substances 
Octenilin® vs. Dermacyn® 9.082 5.958 to 12.21 **** < 0.0001 
Octenilin® vs. Granulox® 10.2 6.627 to 13.77 **** < 0.0001 
Octenilin® vs. 0.004% polihexanide in Ringer Solution 9.322 5.750 to 12.89 **** < 0.0001 
Octenilin® vs. 5% dexpanthenol 10.2 6.627 to 13.77 **** < 0.0001 
Octenilin® vs. 0.698% NaSCN 8.122 4.550 to 11.69 **** < 0.0001 
Octenilin® vs. 0.5% H2O2 4.689 1.116 to 8.262 ** 0.0014 
Octenilin® vs. 1.5% H2O2 4.122 0.5495 to 7.695 ** 0.0096 
Octenilin® vs. 1.5% H2O2+0.698% NaSCN 7.63 4.057 to 11.20 **** < 0.0001 
Octenidin + dexpanthenol + allantoin vs. Dermacyn® 7.571 4.447 to 10.70 **** < 0.0001 
Octenidin + dexpanthenol + allantoin vs. Granulox® 8.689 5.116 to 12.26 **** < 0.0001 
Octenidin + dexpanthenol + allantoin vs. 0.004% 
polihexanide in Ringer Solution 
7.811 4.238 to 11.38 **** < 0.0001 
Octenidin + dexpanthenol + allantoin vs. 5% 
dexpanthenol 
8.689 5.116 to 12.26 **** < 0.0001 
Octenidin + dexpanthenol + allantoin vs. 0.698% NaSCN 6.611 3.038 to 10.18 **** < 0.0001 
Octenidin + dexpanthenol + allantoin vs. 1.5% H2O2 +  
0.698% NaSCN 
6.119 2.546 to 9.692 **** < 0.0001 
Dermacyn® vs. 0.5% chlorhexidine digluconate -8.316 -11.44 to -5.191 **** < 0.0001 
Dermacyn® vs. 0.5% H2O2 -4.393 -7.518 to -1.269 *** 0.0004 
Dermacyn® vs. 1.5% H2O2 -4.96 -8.084 to -1.836 **** < 0.0001 
Granulox® vs. 0.5% chlorhexidine digluconate -9.433 -13.01 to -5.861 **** < 0.0001 
Granulox® vs. 0.5% H2O2 -5.511 -9.084 to -1.938 **** < 0.0001 
Granulox® vs. 1.5% H2O2 -6.078 -9.650 to -2.505 **** < 0.0001 
0.004 % Polihexanide in Ringer solution vs. 0.5% 
chlorhexidine digluconate 
-8.556 -12.13 to -4.983 **** < 0.0001 
0.004% Polihexanide in Ringer solution vs. 0.5% H2O2 -4.633 -8.206 to -1.061 ** 0.0017 
0.004% Polihexanide in Ringer Solution vs. 1.5% H2O2 -5.2 -8.773 to -1.627 *** 0.0002 
0.5% Chlorhexidine digluconate vs. 5% dexpanthenol 9.433 5.861 to 13.01 **** < 0.0001 
0.5% Chlorhexidine digluconate vs. 0.698% NaSCN 7.356 3.783 to 10.93 **** < 0.0001 
0.5% Chlorhexidine digluconate vs. 0.5% H2O2 3.922 0.3495 to 7.495 * 0.0181 
0.5% Chlorhexidine digluconate vs. 1.5% H2O2 +  
0.698% NaSCN 
6.863 3.291 to 10.44 **** < 0.0001 
5% Dexpanthenol vs. 0.5% H2O2 -5.511 -9.084 to -1.938 **** < 0.0001 
5% Dexpanthenol vs. 1.5% H2O2 -6.078 -9.650 to -2.505 **** < 0.0001 




4.3 Verification of microbial contamination  
After finishing the second round of the experiment, it was noticed that most of the eggs 
died after 24h even though incubation, so a contamination test was done to clarify if there 
is a relation between contamination and death of the embryos. According to the 
contamination test, no relation between the contamination of the CAM after 24 hours and 
the death of the eggs was found (Table 26). Figures 41 and 42 show positive results. 
 
Table 26: Results of the contamination test  
Egg number Test substance After 24 hours Findings of 
contamination 
156 0.9% NaCl Alive no contamination 
143 0.9% NaCl Died no contamination 
162 Sodium thiocyanate 0.698% Alive contamination, 
more than 50 cfu 
137 Sodium thiocyanate 0.698%  Died contamination, 
more than 150 cfu 
136 Hydrogen peroxide (H2O2) 
1.5% solution 
Died no contamination 
139 Chlorhexidine 0.5% solution Died no contamination 
 
 
Figure 41: More than 50 colony forming units on blood agar from inoculation of CAM 






Figure 42: More than 150 colony forming units on blood agar from inoculation of CAM 


















5   Discussion 
 
5.1 Method 
The CAM is produced as an extraembryonic membrane on the 4th-6th embryo 
development day (Fuchs and Lindenbaum 1988) as a mesodermal double layer in the 
chicken egg (Bellairs and Osmond 1998). In this double membrane, a capillary system 
develops which is connected to the embryo via arteries and veins (Rizzo et al. 1995). 
The CAM is mainly used for the gas exchange (Rizzo and DeFouw 1993), but also for 
the calcium supply of the embryo from the yolk sac (Bellairs and Osmond 1998, DeFouw 
et al. 1989, Schueller 2005). In addition, the CAM is a pool for nitrogen-containing final 
degradation products (Bellairs and Osmond 1998). The testing on the CAM is not 
classified as an animal test, since no nerve tissue develops in the chicken egg until the 
11th day, so that no pain perception occurs (Liebsch and Spielmann 2002). On the 10th 
day of incubation, a dense capillary network overlays the area of the CAM which is 
adjacent to the air bubble. It allows for a time-dependent assessment of the occurrence 
of hemorrhage, vascular lysis and coagulation in the application area. 
 
The crucial advantage of the HET-CAM assay is the replacement of the Draize Rabbit 
Eye Test (Spielmann et al. 1991, 1993, Spielmann and Liebsch 1991).  The HET-CAM 
offers easy feasibility, sensitivity and low cost. A disadvantage is the subjective 
judgment; this is to be countered by a defined assessment scheme. 
 
As the tolerability to the eye is similar to that of wounds (Kramer et al. 2004, Daeschlein 
et al. 2007, Leaper et al. 2010, Assadian and Kramer 2012, Kramer et al. 2013), more 
recently the HET-CAM is also recommended as a screening test for the evaluation of 
wound healing (Kramer et al. 2013). In case of tolerability of an antiseptic agent in the 
HET-CAM, it can be used on the eye and also on the wound with high probability. This 
is further confirmed by the fact that the tolerability of cold atmospheric pressure plasma 
(CAPP) in HET-CAM (Bender et al. 2010, 2011) was initially confirmed by the enucleated 
eye of slaughter pigs (Hamman et al. 2010). After confirmation of the tolerability of CAPP 
on the porcine ear (Lademann et al. 2009, 2010) and with pet species (Bender et al. 
2013, Bender and Kramer 2016), the prerequisites for the wound treatment of CAPP in 
humans were introduced. In accordance, after therapy try with CAPP, no severe adverse 
effects (SAEs) were observed in any case (Isbary et al.2010, 2012, Heinlin et al. 2013, 
Brehmer et al. 2015, Ulrich et al. 2015). The hypothesis that the tolerability of antiseptic 
agents on the CAM can be used to predict the tolerability of them on wounds is confirmed 




This was the basis for the comparative assessment of selected wound antiseptics on the 
CAM in order to 
• predict the tolerability of the antiseptics on wounds 
• compare antiseptics with each other based on their tolerability 
• draw conclusions about the suitability of the HET-CAM as a test model. 
 
For further studies using the HET-CAM, the following recommendations can be obtained 
from the results: 
• Increasing the number of eggs tested to be 6-9 for each substance 
• monitoring the eggs after 24 hours (physicians need recommendations about the 
less cytotoxic antiseptics in long term use). 
 
5.2 Results 
As expected, the negative control caused no irritation (Table 1). The positive controls 
fulfill the requirements. 1% SDS solution should give an IS of 10 ± 2, 0.1 n NaOH and IS 
of 15 ± 3. 1% SDS should show hemorrhage and lysis within the first minute, whereas 
0.1 n NaOH shows all 3 phenomena, first hemorrhage within several seconds, later 
coagulation and lysis at about 1 minute (Spielmann and Liebsch 1991). 
 
Obvious differences in the tolerability between the commercial available wound 
antiseptics were noticed (Figure 43). In the figure, the IS arranged in ascending order. 
 
 




The wound treatment agent Granulox® spray may have a low antiseptic effect due to the 
content of 0.7% phenoxyethanol; but yet this has not been investigated. The principle is 
that the hemoglobin contained in Granulox®, which is purified from porcine blood, 
transports oxygen from the environment to the wound base and thereby improves wound 
healing. Until the publication of Strohal et al. (2016), a wound healing enhancement was 
demonstrated in 37 clinical trials. However, since the spray can be combined with 
antiseptics such as polihexanide, octenidine and PVP-iodine, the last two have to be 
thoroughly rinsed (Strohal et al. 2016). The finding of the lack of irritation of Granulox® is 
of practical relevance for further considerations to combine it with antiseptics. 
For polihexanide 0.04% in Ringer solution the IS was 0.22, for 0.05% polihexanide in 
Lipofundin® no irritation was induced, both receive the classification "no reaction". 
Analogously Lavanid with the same content of 0.04% polihexanide was tolerated without 
any irritation (Marquardt et al. 2010). This corresponds to the tolerability observed during 
clinical application (Hübner and Kramer 2010, Kramer 2016, Kramer et al. 2017). 
Regarding re-epithelization, 0.04% of polihexanide was significantly superior to PVP-
iodine 10% and silver nitrate 1%. In contrast to PVP-iodine and silver nitrate, no deep 
necrosis and no fibrin deposits were induced by polihexanide (Daeschlein et al. 2007). 
In comparison to chlorhexidine, the re-epithelization of polihexanide was significantly 
faster and less painful (Muangman et al. 2011). In combination with surface active 
betaine the irritation action of polihexanide is increased to “slight reaction”. The same 
irritation response was reported by Marquardt et al. (2010). Deu to the combination, the 
antimicrobial effect is enhanced (Müller et al. 2007, López-Rojasa et al. 2017), the in 
vitro cytotoxicity is reduced (Müller et al. 2007) and cleaning performance is improved 
(Kaehn 2009). The results underline that polihexanide in combination with 
polyethylenglycole is to be preferred for repeated application with therapeutic goal, 
whereas the combination with the betaine is suitable for one-time cleansing of dirty 
contaminated wounds (Kramer et al. 2017). In comparison to 0.89% NaCl solution, 
polihexanide with 2 weeks follow-up period, gave more rapid bacterial elimination, faster 
wound healing, less pain, less exudates and increased granulation (Valenzuela and 
Perucho 2008). In a multi centric study, polihexanide in combination with betaine, gave 
a promotion of wound healing (Durante et al. 2014). 
Dermacyn® wound care follows polihexanide with IS of 1.2 with Irritation score range 
"slight" (Table 24), but the difference was not significant. No wound healing inhibition is 
to be expected clinically, it is even expected that the wound healing will be with low risk 
of inflammation (Kramer et al. 2017). After the successful stabilization of the combination 
of NaOCl/HOCl, an ecological new development has been developed, since aqueous 
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NaCl solution is electrochemically converted to NAOCl/HOCl (the activated solution is 
also referred as super oxidized water) (Thorn et al. 2012). In agreement with the HET-
CAM, there was no evidence for cytotoxicity in the 3D skin model (D'Atanasio et al. 
2015). It should be emphasized that bacterial cells can be killed but human cells survive, 
only by polihexanide (Wiegand et al. 2009) and NaOCl (Crabtree et al. 2001) in co-
culture of bacteria and human cells. This underlines the therapeutic range of both drugs. 
Amazingly, increased number of clinical studies with convincing results on hypochlorite 
wound antiseptics allow the conclusion that hypochlorite based antiseptics are the 
antiseptics of choice of intensive antiseptic, cleaning of contaminated traumatic wounds 
and for repeated antiseptic treatment of chronic wounds until the end of the cleaning 
phase of the wound (Kramer 2016). 
In both tested concentrations of 1.5% and 0.5%, hydrogen peroxide was "moderate" 
irritative. Since hydrogen peroxide practically loses their microbicidal efficacy in this 
concentration range under the action of catalase or peroxidase in the presence of blood 
(Kramer et al. 2008), the active substance is regarded as outdated preventive or 
therapeutic wound antiseptic (Kramer et al. 2004, 2017). This was confirmed in recent 
studies which showed that the rate of surgical site infections of contaminated traumatic 
wounds was significantly more after prophylactic use of hydrogen peroxide 3% when it 
is compared to Ringer's solution, PVP-iodine and polihexanide 0.04% (Roth et al. 2007, 
2017). 
Severe CAM reaction was observed after short-term application of Octenilin® (IS=10.2) 
and chlorhexidine digluconate 0.5% (IS= 9.4) (Table 24). This supports results of 
Marquart et al. (2010). The special feature of both drugs is strong protein binding 
capability (Müller and Kramer 2007), which results in a long time of effect for both drugs 
(Müller and Kramer 2007, Müller et al. 2014). On peritoneal explants, both drugs were 
more cytotoxic than polihexanide (Kramer et al. 1998). In contrast to the severe irritation 
in the HET-CAM and the high cytotoxicity for peritoneal explants, Octenilin does not lead 
to any wound healing inhibition and wounds seem to tolerate it in the same way as 
Ringer's solution (Eisenbeiss et al. 2012). The biocompatibility index is also as for 
polihexanide >1 (Müller and Kramer 2008). Octenidine binds immediately to the 
superficial cells when applied to the wound, and does not reach into the depth due to its 
low percutaneous absorption (Stahl et al. 2011). On the other hand, if the active 
substance is placed under pressure in the skin or in the puncture channels as well as in 
abscess cavities without possible outflow, edematous swelling and tissue damage 
occurs as a result of active substance remaining on the tissue (Höning et al. 2010). 
Therefore, the following recommendation for the use of Octenisept® has been 
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formulated: "To avoid tissue damage, the preparation should not be inserted into the 
depth of the tissue using syringe. The preparation should only be used for superficial 
application as swab or spray" (BfArM/PEI 2016). On the other hand, no local necrosis 
was observed with ensured drainage (Siemers et al. 2011). As a conclusion of the result, 
agents which induce severe CAM irritation and have a high protein binding are not 
recommended to be placed under pressure in a skin tissue or inserted into enclosed 
cavities. 
Considering all additional reasons for the rejection of creams on the base of silver 
sulfadiazine, chlorhexidine, PVP iodine and nitrofural for use as wound antiseptic 
(Kramer et al. 2017), the irritation displayed onto the CAM supports this assessment 
displayed by Marquardt et al. (2010) in HET-CAM for PVP-Iodine cream. In contrast to 
our results the silver sulfadiazine cream induced only slight irritation in the study of 
Marquardt et al. (2010). Bepanthen® cream was better tolerable than Braunovidon® 
ointment after 5 minutes, while Furacin® ointment significantly exceeded the irritation of 
both of them.  
For PVP-iodine, the biocompatibility index was determined to be 0.9 when tested with E. 
coli or 1.0 when tested with S. aureus (Müller and Kramer 2008). In principle, there is 
nothing to oppose its use. As a result of a systematic review (Vermeulen et al. 2010), 
PVP-iodine is excluded from the treatment of chronic wounds due to better alternatives. 
In combination with alcohol, however, PVP-iodine still the antiseptic of choice for 
puncture, incision and shot injuries due to its penetration into the wound (Kramer et al. 
2010, 2017). 
In combination with dexpanthenol, chlorhexidine digluconate meets the requirements for 
an efficient antiseptic (Kramer et al. 2016). As a contraindication, known allergy or 
anaphylaxis due to chlorhexidine must be considered (Garvey et al. 2007, Moka et al. 
2015). It is less effective against Gram-negative bacteria than against Gram-positive 
bacteria (Kramer et al. 2013). A further disadvantage is the possibility of a plasmid 
encoded resistance development (Poole 2007, Fraud et al. 2008, Costa 2013). 
Silver sulfadiazine (SSD), the active ingredient of Flammazine®, is almost completely 
ineffective against S. aureus and E. coli in the presence of 10% fetal calf serum within 
30 minutes (Müller and Kramer 2008). Therefore, it is assumed that the efficacy is 
expected only if the strain is weak. Another disadvantage is the absorption. When applied 
to burn wounds, silver concentrations were determined to 440 μg/l in blood and to 12 
μg/l in urine. As a consequence, monitoring of silver levels in blood and / or urine is 
recommended when using this active ingredient (Maitre et al. 2002). SSD is 
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contraindicated in patients who are hypersensitive to SSD. Because sulfonamide therapy 
is known to increase the possibility of nucleus jaundice, SSD cream should not be used 
on pregnant women at term, premature newborn and infants during the first 2 months of 
life. It is also possible that any adverse reaction associated with sulfonamides may occur, 
such as blood dyscrasias (including agranulocytosis, aplastic anemia, 
thrombocytopenia, leukopenia and hemolytic anemia) and dermatologic and allergic 
reactions (including life-threatening cutaneous reactions "Stevens-Johnson syndrome", 
toxic epidermal necrolysis and exfoliative dermatitis) (Kiker et al. 1977, Jarret et al. 1978, 
Caffe and Bingham 1982, Blangy et al. 2002). In case of renal insufficiency, the use of 
SSD is contraindicated, as prolonged topical use of it for pyoderma with gangrenous 
wounds led to acute renal failure (Chaby et al. 2005). The cytotoxicity of SSD (McCauley 
et al. 1994, Zapata-Sirvent and Hansbrough, 1993) is believed to be the cause of the 
retardation of epidermal regeneration in conjunction with more passive signs of a 
dermatitis-like reaction with spongiosis, parakeratosis, and pseudocarcinoma (Hoekstra 
et al. 1993). Finally, a strong soluble ointment-protein complex is formed on the wound 
surfaces, so that no optical wound assessment is possible in the case of burns. As a 
result, the wound depth cannot be evaluated visually, the exudate remains firmly caked 
with the wound surface and often leads to a too late indication for required operative 
care, which subsequently leaves either scars or loss of vital tissue including higher blood 
loss due to excision. In addition, maceration with the colonization of these wounded 
areas causes highly resistant wet bacteria such as P. aeruginosa, which are often difficult 
to control. As a consequence, surgery must be done more frequently in order to prevent 
serious defects and possibly generalization of the infection. This situation is repeatedly 
observed in secondary assignments of burn injuries which were treated with SSD for 
more than 5 days. Therefore, the use of SSD for healing is rather undesirable and it lacks 
the ability to assess changes in the wound area (Kramer et al. 2004, 2017). The use of 
SSD for burns is unnecessary because of the low efficacy, the risk of local and systemic 
side effects including the development of resistance and the presence of better 
alternatives (Kramer and Richweed 2008a, Kramer et al. 2017). 
The active substance nitrofurazone (syn. nitrofural) is only slightly active against S. 
aureus (reduction approx. 1.5 log) and ineffective against C. albicans, however effective 
against P. aeruginosa (Hygiene Nord GmbH 2005). Blood and serum significantly reduce 
the efficacy (Coffey et al. 1991). At the same time, the active substance is highly cytotoxic 
(Kramer et al. 2008c). According to this, wound healing was significantly delayed by 
nitrofurazone 0.2% compared to the control in a full-thickness wound model in rats 
(Saydam et al. 2006). Nitrofurazone is no longer recommended for wound antisepsis 
because of its insufficient antibacterial effects, the risk of resistance development, the 
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high sensitization potential, the high cytotoxicity, the lack of quantification for absorption 
from wounds and the unexplained carcinogenic and teratogenic/ fetotoxic hazard when 
applied to wounds (Kramer et al. 2004, 2008c). 
Wilson and Steck (2000) also used the HET-CAM as a test model in order to examine 
anti-irritative effects. Due to the absence of observed irritative effects, dexpanthenol and 
allantoin are both possible additives for antiseptics in order to promote wound healing. 
Pantothenic acid (vitamin B5) and its biologically active precursor dexpanthenol activate 
the proliferation of fibroblasts, promote the formation of collagen fibers, stimulate the 
regeneration of damaged tissue and have an anti-inflammatory and antioxidative effect 
(Proksch et al. 2002, Oguz et al. 2015, Ulger et al. 2016). Dexpanthenol therefore has 
been combined in topical antimicrobial preparations, both antiseptics and antibiotics, 
intended to be used on wounds (Kramer et al. 2016). Additionally, the antiseptic efficacy 
of chlorhexidine is increased by adding 5% dexpanthenol (Kramer et al. 2016). Animal 
experiments also displayed promotion of wound healing in animal experiments via 
regulation of inflammatory response as wells stimulus to fibroblastic proliferation and 
extracellular matrix synthesis (Jorge et al. 2008, Araujo et al. 2010). Since there seems 
to be no irritative effect, it is also a possible partner for antiseptics. The irritative effect of 
octenidine was only slightly reduced by addition of 1.34% dexpanthenol and 0.2 allantoin. 
Sodium thiocyanate (NaSCN) 0.698% caused a "slight reaction". NaSCN has an 
antiphlogistic effect (Kramer and Weuffen 1996, Kramer 2002) and stimulates 
proliferation of fibroblasts (Machill et al. 1987). Further examinations for the suitability of 
using NaSCN in combination with wound antiseptics have to be done.  
Because sodium thiocyanate particularly promotes the proliferation of rapidly dividing 
tissues as in spermiogenesis (Gromoll et al. 1990), stimulates hair formation (Kramer et 
al. 1990a, 1990b, 1996, Minnich et al. 1991, Sima et al. 1995) and proliferation of 
fibroblasts in cell culture (Adrian et al. 1987, Machill et al. 1987), stimulates wound 
healing in plant and mammals (Koch 1989), acts antiphlogistically in vitro and in vivo 
(Kramer and Weuffen 1996), stimulates phagocytosis in wound secretions (Jahr et al. 
1986), therefore, the finding that the irritation was reduced from "moderate" to "slight" by 
the addition of NaSCN to hydrogen peroxide is interesting for any future work. 
The small standard deviation of hydrogen peroxide in both concentrations of 1.5% and 
0.5% indicates that the results are clustered closely around the mean. The standard 
deviations of both positive controls, of polihexanide 0.04% in Ringer solution, 
Dermacyn®, sodium thiocyanate 0.698%, hydrogen peroxide 1.5 % + sodium thiocyanate 
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0.698% and octenidine 0.05% + panthenol 1.34% + allantoin 0.2% ranged between (1.5-
2.61). These values signify accepted dispersions statistically.  
Figure 44 shows the percentage of eggs that remained alive after 24 hours, for the 
negative control and 4 formulations, the range was between 22% and 59%. All the eggs 
which were tested with the remaining formulations died after 24 hours. Control of 
bacterial contamination on the eggs after 24 hours was done in order to find if a 
contamination of the CAM was the cause of eggs death, but no correlation was found. 
Thus, the explanation of this phenomenon is unclear.  
 
 
Figure 44: Percentage of living eggs after 24 hours  
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6   Conclusion  
 
The vascular injuries caused by the tested antiseptics can be considered as an indirect 
indicator of their wound tolerability. It is suggested that substances with no or low 
irritation potential on the CAM to be preferred in the clinical practice.  
From the tested wound antiseptics, polihexanide and hypochlorite are tolerable without 
restriction. The same is true for the tested wound oxygenizer.  
It appears to be promising to test mixtures of common used antiseptic agents with 
additives, which could increase the tolerability of the antiseptics, i.e. dexpanthenol, 
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